Palmoplantar Keratoderma Market Size
Market Size in USD Bn
CAGR2.7%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 2.7% |
| Market Concentration | High |
| Major Players | LEO Pharma, Novartis AG, Pfizer, GlaxoSmithKline (GSK), AbbVie and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Palmoplantar Keratoderma Market Analysis
The palmoplantar keratoderma market is estimated to be valued at USD 1.24 Billion in 2025 and is expected to reach USD 1.49 Billion by 2032, growing at a compound annual growth rate (CAGR) of 2.7%. This growth can be attributed to the rising prevalence of palmoplantar keratoderma, which leads to thickening of skin on the palms and soles.